Multiple Myeloma and Bone: The Fatal Interaction-Reference-Cited by-同舟云学术

Multiple Myeloma and Bone: The Fatal Interaction

Published:2017-12-11 Issue:8 Volume:8 Page:a031286
ISSN:2157-1422
Container-title:Cold Spring Harbor Perspectives in Medicine
language:en
Short-container-title:Cold Spring Harb Perspect Med

Author:

Marino Silvia,Roodman G. David

Publisher

Cold Spring Harbor Laboratory

Subject

General Biochemistry, Genetics and Molecular Biology

Reference200 articles.

1. Tumor necrosis factor-α inhibits pre-osteoblast differentiation through its type-1 receptor

2. Role for macrophage inflammatory protein (MIP)-1α and MIP-1β in the development of osteolytic lesions in multiple myeloma;Blood,2002

3. Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion

4. Mechanism of action of bortezomib and the new proteasome inhibitors on myeloma cells and the bone microenvironment: Impact on myeloma-induced alterations of bone remodeling;Biomed Res Int,2015

5. EZH2 or HDAC1 Inhibition Reverses Multiple Myeloma–Induced Epigenetic Suppression of Osteoblast Differentiation

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extramedullary plasmacytoma in the stomach of a nine-year-old Chihuahua with severe gastric emptying disorder and anemia after tumor resection;KLEINTIERPRAXIS;2024

2. Anticancer effect of minor phytocannabinoids in preclinical models of multiple myeloma;BioFactors;2024-05-17

3. Pharmacologic targeting of the p62 ZZ domain enhances both anti-tumor and bone-anabolic effects of bortezomib in multiple myeloma;Haematologica;2023-11-16

4. Multiple Myeloma and the Role of Bisphosphonates in Its Management;Cureus;2023-09-14

5. Expression of the Purinergic P2X7 Receptor in Murine MOPC315.BM Myeloma Cells;Receptors;2023-09-07